Dawn Bertsch Porter v. Eli Lilly and Company

291 F. App'x 963

• Court: Court of Appeals for the Eleventh Circuit
• Decided: September 9, 2008
• Docket: 08-11335
• Status: Unpublished

Opinion

PER CURIAM:

This is an appeal from the district court’s grant of summary judgment in favor of defendant Eli Lilly and Company (“Eli Lilly”). Plaintiff Dawn Bertsch Porter (“Porter”) brought an action against Eli Lilly contending that it was responsible for the suicide of her husband, Leland “Lee” Porter, because Eli Lilly failed to adequately warn of the potential risks between the drug Prozac and suicide. We review a district court’s grant of summary judgment de novo. Eley v. Baptist Hosp. Worth County, Inc., 199 Fed.Appx. 757, 758 (11th Cir.2006).

After reviewing the record and reading the parties’ briefs, we conclude that the district court correctly granted Eli Lilly’s motion for summary judgment based on Porter’s failure to produce evidence of proximate cause. See Powell v. Harsco Carp., 209 Ga.App. 348, 433 S.E.2d 608, 610 (1993). Under Georgia law, Porter was required to prove that, but for the alleged inadequate warning, Dr. Wolfberg, decedent’s physician, would not have prescribed Prozac to decedent. See Wheat v. Sofamor, S.N.C., 46 F.Supp.2d 1351, 1363 (N.D.Ga.1999). Dr. Wolfberg unequivocally testified that even if he had read the warning that Porter asserts should have been given, he still would have prescribed Prozac to the decedent. Thus, we agree with the district court that Porter cannot prove that Prozac was the proximate cause of decedent’s death.

Because there is no merit to any of the arguments Porter makes in this appeal, we affirm the district court’s grant of summary judgment in favor of Eli Lilly.

AFFIRMED.